|
PAPOLA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.062840E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.81890000000063E-05 |
| Normal-vs-Stage2 |
1.084960E-01 |
| Normal-vs-Stage3 |
5.299400E-01 |
| Normal-vs-Stage4 |
6.173400E-01 |
| Stage1-vs-Stage2 |
4.412600E-01 |
| Stage1-vs-Stage3 |
5.800000E-02 |
| Stage1-vs-Stage4 |
2.230400E-01 |
| Stage2-vs-Stage3 |
4.814000E-01 |
| Stage2-vs-Stage4 |
5.810000E-01 |
| Stage3-vs-Stage4 |
9.641200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.587900E-04 |
| Normal-vs-AfricanAmerican |
1.151520E-02 |
| Normal-vs-Asian |
6.801600E-01 |
| Caucasian-vs-AfricanAmerican |
7.781400E-01 |
| Caucasian-vs-Asian |
5.737800E-01 |
| AfricanAmerican-vs-Asian |
6.069200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.38879999999919E-05 |
| Normal-vs-Female |
6.562800E-01 |
| Male-vs-Female |
9.120200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.243800E-02 |
| Normal-vs-Extreme_Weight |
1.555380E-04 |
| Normal-vs-Obese |
1.673800E-01 |
| Normal-vs-Extreme_Obese |
5.472500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.456800E-01 |
| Normal_Weight-vs-Obese |
3.258400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.095200E-01 |
| Extreme_Weight-vs-Obese |
5.356000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.188400E-01 |
| Obese-vs-Extreme_Obese |
2.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.181800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.995900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.42379999999542E-05 |
| Normal-vs-Age(81-100Yrs) |
9.610700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.134830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.010400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.290100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.511900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.781200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.914600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.447220E-04 |
| Normal-VS-Type2 PRCC |
3.643600E-04 |
| Normal-VS-KIRP CIMP |
9.720300E-02 |
| Normal-VS-Unclassified PRCC |
4.395900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.751600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.820410E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.854800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.188140E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.775200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.839100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77482000000007E-05 |
| Normal-vs-N1 |
2.066600E-01 |
| Normal-vs-N2 |
2.337500E-03 |
| N0-vs-N1 |
8.445200E-04 |
| N0-vs-N2 |
4.791200E-01 |
| N1-vs-N2 |
5.914000E-02 |
|
|
